# OnCo record rnf213 (target). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/targets/rnf213/>
  a schema:BioChemEntity ;
  onco:kind "target" ;
  schema:identifier "rnf213" ;
  schema:name "RNF213"@en ;
  schema:alternateName "ring finger protein 213"@en, "E3 ubiquitin-protein ligase RNF213"@en, "KIAA1554"@en, "NET57"@en, "ALO17"@en, "C17orf27"@en, "KIAA1618"@en, "MYMY2"@en, "RNF213" ;
  schema:description "RNF213 (E3 ubiquitin-protein ligase RNF213) is an enzyme. The public catalogues list it as an oncogene driver, a tumour suppressor and a fusion partner, and it is called a cancer driver by mutation analysis of patient cohorts. Tied to Prostate cancer, Bladder & urothelial cancer, Renal cell carcinoma and 5 more."@en ;
  schema:url <https://onco.cc/targets/rnf213/> ;
  schema:dateModified "2026-09-23"^^xsd:date ;
  schema:citation <https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:14539>, <https://www.uniprot.org/uniprotkb/Q63HN8/entry>, <https://www.ncbi.nlm.nih.gov/gene/57674>, <https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000173821> ;
  onco:tag "cancer-genes-wave" ;
  onco:targetClass "enzyme" ;
  schema:sameAs <https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:14539>, <https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000173821>, <https://www.uniprot.org/uniprotkb/Q63HN8/entry>, <https://www.ncbi.nlm.nih.gov/gene/57674> ;
  onco:related <https://onco.cc/collections/intogen/> ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/urothelial/>, <https://onco.cc/cancers/rcc/>, <https://onco.cc/cancers/esophageal/>, <https://onco.cc/cancers/endometrial/>, <https://onco.cc/cancers/angiosarcoma/>, <https://onco.cc/cancers/clear-cell-rcc/>, <https://onco.cc/cancers/cholangiocarcinoma/> .